AIMC Topic: Clinical Trials as Topic

Clear Filters Showing 201 to 210 of 271 articles

CRT 2025 late-breaking trials: Key takeaways.

Cardiovascular revascularization medicine : including molecular interventions
The Cardiovascular Research Technologies (CRT) 2025 conference, a prominent gathering in the field of cardiology, convened more than three thousand attendees from around the world. CRT provides a forum for exemplary education for interventional cardi...

RoBIn: A Transformer-based model for risk of bias inference with machine reading comprehension.

Journal of biomedical informatics
OBJECTIVE: Scientific publications are essential for uncovering insights, testing new drugs, and informing healthcare policies. Evaluating the quality of these publications often involves assessing their Risk of Bias (RoB), a task traditionally perfo...

A Semi-Automated Approach Based on Network Analysis to Suggest New Collaborations and Foster Multisite Clinical Trials.

Studies in health technology and informatics
Several research institutions nowadays collaboratively conduct many scientific projects. Within a national Italian initiative on robotic rehabilitation, this study aims to develop new collaborations that can support the project's missions. Bibliograp...

AI-driven predictive biomarker discovery with contrastive learning to improve clinical trial outcomes.

Cancer cell
Modern clinical trials can capture tens of thousands of clinicogenomic measurements per individual. Discovering predictive biomarkers, as opposed to prognostic markers, remains challenging. To address this, we present a neural network framework based...

AI-Driven Applications in Clinical Pharmacology and Translational Science: Insights From the ASCPT 2024 AI Preconference.

Clinical and translational science
Artificial intelligence (AI) is driving innovation in clinical pharmacology and translational science with tools to advance drug development, clinical trials, and patient care. This review summarizes the key takeaways from the AI preconference at the...

AI meets informed consent: a new era for clinical trial communication.

JNCI cancer spectrum
Clinical trials are fundamental to evidence-based medicine, providing patients with access to novel therapeutics and advancing scientific knowledge. However, patient comprehension of trial information remains a critical challenge, as registries like ...

The use of large language models to enhance cancer clinical trial educational materials.

JNCI cancer spectrum
BACKGROUND: Adequate patient awareness and understanding of cancer clinical trials is essential for trial recruitment, informed decision making, and protocol adherence. Although large language models (LLMs) have shown promise for patient education, t...

Artificial intelligence and digital tools for design and execution of cardiovascular clinical trials.

European heart journal
Recent advances have given rise to a spectrum of digital health technologies that have the potential to revolutionize the design and conduct of cardiovascular clinical trials. Advances in domain tasks such as automated diagnosis and classification, s...

A Tutorial and Use Case Example of the eXtreme Gradient Boosting (XGBoost) Artificial Intelligence Algorithm for Drug Development Applications.

Clinical and translational science
Approaches to artificial intelligence and machine learning (AI/ML) continue to advance in the field of drug development. A sound understanding of the underlying concepts and guiding principles of AI/ML implementation is a prerequisite to identifying ...

Agents for Change: Artificial Intelligent Workflows for Quantitative Clinical Pharmacology and Translational Sciences.

Clinical and translational science
Artificial intelligence (AI) is making a significant impact across various industries, including healthcare, where it is driving innovation and increasing efficiency. In the fields of Quantitative Clinical Pharmacology (QCP) and Translational Science...